Perstorp is making progress in ‘future-proofing’ its Capa caprolactone monomer plant in Warrington, UK. The monomer plant will be made more robust to ensure an even more reliable supply for customers around the world, the company announced.
Perstorp/Sweden — This investment is also intended to facilitate future debottlenecking to support market growth. The company is building in the capability for the plant to run with a higher capacity, which allows for increased production volumes in the future. In addition, the manufacturer is now starting to debottleneck its Capa derivatives production units at Warrington.
Stephen Lewis, Vice President Business Unit Caprolactones, continues to see strong confidence and demand in the caprolactone market, and in particular for the company's range of caprolactone derivatives marketed under the names Capa Thermoplastics and Capa Polyols.
In particular, the strong growth was largely driven by the customers’ recognition of the unique properties and performance advantages of the Capa product range, he added. Capa Thermoplastics are utilized in diverse application areas such as Adhesives and Sealants, Medical, Bioplastics and Footwear. An increasing demand would lead to a strong need to invest in additional capacity, in order to ensure the supplier meets customer’s future requirements and growth plans in a timely manner.